Work with thought leaders and academic experts in anesthesiology and pain medicine

Companies can greatly benefit from working with experts in the field of anesthesiology and pain medicine. These professionals bring a wealth of knowledge and experience that can contribute to various projects and initiatives. Here are five ways companies can collaborate with academic researchers in this field: 1. Research and Development: Anesthesiology and pain medicine experts can provide valuable insights and contribute to the development of new drugs, medical devices, and treatment protocols. 2. Clinical Trials: Companies conducting clinical trials can partner with these experts to design and oversee studies, ensuring the safety and efficacy of new treatments. 3. Pain Management Solutions: Academic researchers can help companies develop innovative pain management solutions, including non-pharmacological approaches and personalized treatment plans. 4. Education and Training: Collaborating with experts in anesthesiology and pain medicine can enhance the education and training programs offered by companies in the healthcare industry. 5. Consulting and Advisory Services: Companies can leverage the expertise of these thought leaders to provide consulting and advisory services, helping them make informed decisions and navigate complex challenges.

Researchers on NotedSource with backgrounds in anesthesiology and pain medicine include Daniel Milej, Ph.D., Samuel Ojima Adejoh, Dr. Christian Waugh, Ph.D., Carissa Clark, Luke Connelly, Dr. Clay Wilson, Ph.D., Alexandria Pavelich, MA, PhD(c), Doaa Wafik, Gwendolyn Thomas, Ph.D., and Ahmed Barakat.

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Expertise
Anesthesiology and Pain Medicine
Other Research Expertise (43)
Health economics
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 38 more
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link]( process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.

See Full Profile

Doaa Wafik

Associate professor of economics, Head of quality assurance unit
Most Relevant Research Expertise
Anesthesiology and Pain Medicine
Other Research Expertise (13)
Economics and finance
Pharmacology (medical)
Psychiatry and Mental health
Neuropsychology and Physiological Psychology
Management of Technology and Innovation
And 8 more
Doaa Wafik is a highly educated and experienced economist with a strong background in finance and accounting. She received her Ph.D. in Economics and Finance from Ain Shams University in 2006 and her Master's degree in Economics from the same university in 2001. She also holds a Bachelor's degree in Accounting from Ain Shams University, which she earned in 1994. With over 15 years of experience in the field, Doaa has established herself as an expert in economics and finance. She currently serves as an Associate Professor of Economics and the Head of the Quality Assurance Unit at Newgiza University. In this role, she is responsible for ensuring the academic quality and standards of the university's programs and courses. Doaa's extensive knowledge and expertise in economics and finance have made her a sought-after consultant and speaker. She has participated in numerous conferences and workshops, both nationally and internationally, and has published several research papers in reputable academic journals. Her dedication to her field and commitment to academic excellence make Doaa a valuable asset in any organization. She continues to contribute to the advancement of economics and finance through her teaching, research, and consulting activities.

See Full Profile

Gwendolyn Thomas, Ph.D.

Degreed Exercise Physiologist (PhD) with 15+ years experience in clinical research in oncology, obesity and chronic disease. Strong investigative and analytical skills that fostered relationships with expert faculty and collaborators across department, division and institution, as well as within industry, foundations and government to develop Clinical Trial Protocols, scientific publications, and presentations.
Most Relevant Research Expertise
Anesthesiology and Pain Medicine
Other Research Expertise (28)
resistance exercise
breast cancer
chronic disease
And 23 more
Strong training and experience in clinical research regulatory requirements as both Principal Investigator and Internal Review Board member.Strong analytical skills with the ability to interpret clinical trial data and synthesize conclusions. Facilitates interactions between key stakeholders across department, division, institution and industry and government partners using a proactive approach, strategic thinking and leadership to accomplish study goals and timelines. Ability to manage multiple competing priorities with good planning, time management and prioritization skills. Project milestones met through problem solving, prioritization, conflict resolution and critical thinking skills. Advanced communication, scientific writing and presentation skills at both university and national/international stakeholder conferences. As Principal Investigator responsibilities include completing high quality literature reviews of clinical trials, peer-reviewed articles, clinical guidelines and other medical data sources to allow for oversight of project deliverables. Extensive experience in independently designing and developing abstracts for peer-reviewed publications, scientific posters and podium presentations at both national and international conferences.

See Full Profile

Example anesthesiology and pain medicine projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on anesthesiology and pain medicine?

Development of a New Pain Medication

An academic researcher in anesthesiology and pain medicine can collaborate with a pharmaceutical company to develop a new pain medication. Their expertise in pain management and understanding of the underlying mechanisms can contribute to the formulation and testing of the drug.

Improving Surgical Techniques

By partnering with anesthesiology and pain medicine experts, surgical equipment manufacturers can improve their products and develop new techniques that minimize pain and discomfort during and after surgery. This collaboration can lead to advancements in surgical procedures and better patient outcomes.

Designing Non-Pharmacological Pain Management Solutions

Companies specializing in non-pharmacological pain management can collaborate with academic researchers to design and develop innovative solutions. This can include techniques such as acupuncture, physical therapy, and cognitive-behavioral therapy, which can be integrated into comprehensive pain management programs.

Optimizing Anesthesia Delivery Systems

Medical device manufacturers can partner with anesthesiology experts to optimize anesthesia delivery systems. This collaboration can lead to the development of safer and more efficient devices, improving patient comfort and reducing the risk of complications during surgical procedures.

Enhancing Postoperative Pain Management

Collaborating with academic researchers in anesthesiology and pain medicine can help pharmaceutical companies develop new drugs and treatment protocols for postoperative pain management. This can lead to more effective pain relief options and improved recovery outcomes for patients.